Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer

Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: A short follow-up

(2017) Nervana Samy et al.   Cancer Biomarkers

The Significance of CA15-3 in Breast Cancer Patients and its Relationship to HER-2 Receptor Status

(2017) Z.M. Hashim   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients

(2014) Mariarosaria Incoronato et al.   BMC CANCER

Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives

(2014) Felipe Ades et al.   JOURNAL OF CLINICAL ONCOLOGY

A Nation-Wide Multicenter 10-Year (1999-2008) Retrospective Clinical Study of Endocrine Therapy for Chinese Females with Breast Cancer

(2014) Can Zhou et al.   PLoS One

Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft

(2014) Nirma Skrbo et al.   PLoS One

Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer

(2013) San-gang Wu et al.   BREAST

Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers

(2013) Jun Sang Lee et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast cancer statistics, 2013

(2013) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer

(2013) Ann Christina Pedersen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer

(2013) Nan Dai et al.   PLoS One

Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer

(2012) J. S. Lee et al.   ANNALS OF ONCOLOGY

Prognostic Value of Molecular Subtypes, Ki67 Expression and Impact of Postmastectomy Radiation Therapy in Breast Cancer Patients With Negative Lymph Nodes After Mastectomy

(2012) Jessica Selz et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Gene expression profiling in breast cancer: classification, prognostication, and prediction

(2011) Jorge S Reis-Filho et al.   LANCET

Kinetics of CEA and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC)

(2011) Dorit Di Gioia et al.   TUMOR BIOLOGY

Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer

(2008) Masahiro Uehara et al.   International Journal of Clinical Oncology

Inconsistent Criteria Used in American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

(2008) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY